Unknown OBSERVATIONAL NCT05486351

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke (KOALA-IS)

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic

Sponsor: Daiichi Sankyo

Conditions Anticoagulant Therapy Cardioembolic Stroke Haemorrhagic Transformation Stroke Stroke Recurrence

Interventions Observation

Updated 5 times since 2022 Last updated: Aug 2, 2022 Started: Mar 5, 2021 Primary completion: Dec 31, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05486351, this observational or N/A phase trial focuses on Anticoagulant Therapy and Cardioembolic Stroke and remains ongoing. Sponsored by Daiichi Sankyo, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Aug 2024 — Sep 2024 [monthly]

Unknown

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting
Sep 2022 — Mar 2024 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo
Fundación Freno al ICTUS
Hospital Universitario La Paz
Instituto de Investigación Hospital Universitario La Paz

Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain
• Paris, France